A randomised controlled unblinded multicentre non-inferiority trial with activated vitamin D and prednisolone treatment in patients with minimal change nephropathy (ADAPTinMCN)

Peer Review reports

Original Submission
15 Mar 2021	Submitted	Original manuscript
8 Apr 2021	Reviewed	Reviewer Report - Muslim Syed
24 May 2021	Reviewed	Reviewer Report - Limy Wong
22 Jun 2021	Author responded	Author comments - Tilde Kristensen
Resubmission - Version 2
22 Jun 2021	Submitted	Manuscript version 2
Publishing
23 Jun 2021	Editorially accepted
12 Jul 2021	Article published	10.1186/s13063-021-05393-4

Back to article page